Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer

BACKGROUND: The role of estrogen receptor beta (ER-β) in breast cancer (BC) remains unclear. Some studies have suggested that ER-β may oppose the actions of estrogen receptor alpha (ER-α), and clinical evidence has indicated that the loss of ER-β expression is associated with a poor prognosis and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Madeira, Marcelo, Mattar, André, Logullo, Ângela Flávia, Soares, Fernando Augusto, Gebrim, Luiz Henrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851532/
https://www.ncbi.nlm.nih.gov/pubmed/24047421
http://dx.doi.org/10.1186/1471-2407-13-425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851532/
https://www.ncbi.nlm.nih.gov/pubmed/24047421
http://dx.doi.org/10.1186/1471-2407-13-425

Ejemplares similares